Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1991 Dec;64(6):1039–1042. doi: 10.1038/bjc.1991.461

Expression of members of the myf gene family in human rhabdomyosarcomas.

J Clark 1, P J Rocques 1, T Braun 1, E Bober 1, H H Arnold 1, C Fisher 1, C Fletcher 1, K Brown 1, B A Gusterson 1, R L Carter 1, et al.
PMCID: PMC1977834  PMID: 1764365

Abstract

Northern analysis of tumour RNA has been used to examine the expression of members of the myf family of muscle determining genes (myf3, myf4, myf5 and myf6) in a series of 20 rhabdomyosarcomas. A 2.0 kb myf3 transcript was observed in 85% of tumours, a 1.8 kb myf4 transcript was detected in 70% of tumours and a 1.7 kb myf5 transcript was observed in 55% of tumours. Transcription of myf6 occurred in 28% of tumours, but there were several transcript sizes (1.2, 1.5, 2.0 and 3.5 kb) and in some individual tumours two or more transcripts were observed. Only two rhabdomyosarcomas, one classified as embryonal and one as pleomorphic, failed to exhibit transcription of members of the myf gene family. We were unable to detect transcription of myf genes in neuroblastomas, Wilms' tumours, hepatoblastomas, paediatric non-Hodgkin's lymphoma and leiomyosarcomas. When considered together these observations suggest that expression of myf genes could provide an extremely useful marker in the diagnosis of rhabdomyosarcoma.

Full text

PDF
1039

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braun T., Bober E., Buschhausen-Denker G., Kohtz S., Grzeschik K. H., Arnold H. H., Kotz S. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 1989 Dec 1;8(12):3617–3625. doi: 10.1002/j.1460-2075.1989.tb08535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Braun T., Bober E., Winter B., Rosenthal N., Arnold H. H. Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12. EMBO J. 1990 Mar;9(3):821–831. doi: 10.1002/j.1460-2075.1990.tb08179.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Braun T., Buschhausen-Denker G., Bober E., Tannich E., Arnold H. H. A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J. 1989 Mar;8(3):701–709. doi: 10.1002/j.1460-2075.1989.tb03429.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Carter R. L., Jameson C. F., Philp E. R., Pinkerton C. R. Comparative phenotypes in rhabdomyosarcomas and developing skeletal muscle. Histopathology. 1990 Oct;17(4):301–309. doi: 10.1111/j.1365-2559.1990.tb00733.x. [DOI] [PubMed] [Google Scholar]
  5. Carter R. L., McCarthy K. P., Machin L. G., Jameson C. F., Philp E. R., Pinkerton C. R. Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle. Histopathology. 1989 Dec;15(6):585–595. doi: 10.1111/j.1365-2559.1989.tb01624.x. [DOI] [PubMed] [Google Scholar]
  6. Davis R. L., Weintraub H., Lassar A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987 Dec 24;51(6):987–1000. doi: 10.1016/0092-8674(87)90585-x. [DOI] [PubMed] [Google Scholar]
  7. Dodd S., Malone M., McCulloch W. Rhabdomyosarcoma in children: a histological and immunohistochemical study of 59 cases. J Pathol. 1989 May;158(1):13–18. doi: 10.1002/path.1711580105. [DOI] [PubMed] [Google Scholar]
  8. Feramisco J. R., Smart J. E., Burridge K., Helfman D. M., Thomas G. P. Co-existence of vinculin and a vinculin-like protein of higher molecular weight in smooth muscle. J Biol Chem. 1982 Sep 25;257(18):11024–11031. [PubMed] [Google Scholar]
  9. Garvin A. J., Stanley W. S., Bennett D. D., Sullivan J. L., Sens D. A. The in vitro growth, heterotransplantation, and differentiation of a human rhabdomyosarcoma cell line. Am J Pathol. 1986 Oct;125(1):208–217. [PMC free article] [PubMed] [Google Scholar]
  10. Hiti A. L., Bogenmann E., Gonzales F., Jones P. A. Expression of the MyoD1 muscle determination gene defines differentiation capability but not tumorigenicity of human rhabdomyosarcomas. Mol Cell Biol. 1989 Nov;9(11):4722–4730. doi: 10.1128/mcb.9.11.4722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Schmidt R. A., Cone R., Haas J. E., Gown A. M. Diagnosis of rhabdomyosarcomas with HHF35, a monoclonal antibody directed against muscle actins. Am J Pathol. 1988 Apr;131(1):19–28. [PMC free article] [PubMed] [Google Scholar]
  12. Stratton M. R., Moss S., Warren W., Patterson H., Clark J., Fisher C., Fletcher C. D., Ball A., Thomas M., Gusterson B. A. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene. 1990 Sep;5(9):1297–1301. [PubMed] [Google Scholar]
  13. Wright W. E., Sassoon D. A., Lin V. K. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 1989 Feb 24;56(4):607–617. doi: 10.1016/0092-8674(89)90583-7. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES